Table 8 VRK2 as prognostic index in astrocytomas
From: VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis
Risk group | No. patients % | Hazard ratio (95% C.I.) | Median survival (months) (95% C.I.) | P value | Survival rate | ||
|---|---|---|---|---|---|---|---|
1-year | 2-year | 3-year | |||||
Low-risk | 28 (37.8%) | 1 | 15.7 (12.3 – 19.0) | <0.001 | 67.9% | 25.5% | 21.3% |
High-risk | 46 (62.2%) | 2.64 (1.53 – 4.55) | 9.8 (7.9 – 11.8) | 39.8% | 7.0% | 0.0% | |